Among participants taking antihypertensive medication with above-goal BP (ie, systolic BP 130 mmHg or dia- stolic BP 80 mmHg), the incidences of ASCVD and all-cause death were 33.6 and 42.5 events per 1000 In addition, individuals with HBP face on average nearly $2000 more in annual healthcare expenses than those without HBP.19 Table 3. Guideline Recommendation for BP-Lowering Medications: ACC/AHA COR/LOE ASCVD Risk Stage 2 High BP Stage 1 High BP mmHg) Elevated BP mmHg) ASCVD Risk COR: 1, LOE: A COR: 1, LOE: A Not recommended ASCVD Risk COR: 1, LOE: C-LD Not recommended Not recommended All require intensive lifestyle modification (COR: 1, LOE: A) (applies to the entire table). For older adults ( 65 years of age) with hypertension and a high burden of comorbidity and limited life expectancy, clinical judgment, patient preference, and a team-based approach to assess risk/benefit are reasonable for decisions about intensity of BP lowering and choice of antihypertensive drugs (COR: 2a, LOE: C-EO). ACC indicates American College of Cardiology; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; COR, Class of Recommendation; and LOE, Level of Evidence. Table 2. BP Classification (JNC 7 and the 2017 Hypertension Clinical Practice Guidelines) SBP (mmHg) and/or DBP (mmHg) <120 and <80 Normal BP Normal BP 120 129 and <80 Prehypertension Elevated BP hypertension hypertension hypertension hypertension hypertension BP should be based on an average of 2 careful readings on 2 occasions. Adults with SBP or DBP in 2 categories should be designated to the higher BP category. BP indicates blood pressure; DBP, diastolic blood pressure; GL, guideline; JNC, Joint National Committee; and SBP, systolic blood pressure. 